A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Allan-Blitz, Lao-TzuHemarajata, Peera
Humphries, Romney M.
Wynn, Adriane
Segura, Eddy R.
Klausner, Jeffrey D.
Issue Date
2018-02Keywords
AzithromycinCeftriaxone
Ciprofloxacin
DNA topoisomerase (ATP hydrolysing) A
Antibiotic resistance
Antibiotic sensitivity
Chlamydiasis
Cost benefit analysis
Metadata
Show full item recordCitation
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection 2018, 45 (2):87 Sexually Transmitted DiseasesPublisher
Lippincott Williams and WilkinsJournal
Sexually Transmitted DiseasesDOI
10.1097/OLQ.0000000000000698Additional Links
http://Insights.ovid.com/crossref?an=00007435-201802000-00004Abstract
From the *Division of Infectious Diseases, Department of Medicine, †Department of Laboratory Medicine, David Geffen School of Medicine, Department of Medicine, ‡Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA; §Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Peru; and ¶Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA Conflict of Interest and Sources of Funding: None declared. This research was supported by the United States National Institutes of Health grants R21AI117256 and R21AI109005 as well as the South American Program in HIV Prevention Research NIH/NIMH R25MH087222. Correspondence: Lao-Tzu Allan-Blitz, MD Candidate, 2018, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095. E‐mail: [email protected]. Received for publication February 21, 2017, and accepted July 30, 2017. DOI: 10.1097/OLQ.0000000000000698Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/restrictedAccessLanguage
engDescription
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.ISSN
0148-5717ae974a485f413a2113503eed53cd6c53
10.1097/OLQ.0000000000000698
Scopus Count
Collections